Latest News about GSK
Recent news which mentions GSK
3 Penny Stocks That Could Make You Filthy Rich
January 25, 2023
From Motley Fool
From Benzinga
From Motley Fool
From Benzinga
Moderna Gets A 'Booster' Shot: Why Stock Is Up Nearly 7% Today
January 18, 2023
From Benzinga
Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response
January 09, 2023
From MarketWatch
From InvestorPlace
GSK Looking For Under-Appreciated M&A Targets, Not Trying To Be Next Roche Or AstraZeneca
December 30, 2022
From Benzinga
7 Drug Stocks That Will Soar in 2023
December 22, 2022
From InvestorPlace
2 Smartest Tech Stocks to Buy in 2022 and Beyond
December 20, 2022
From Motley Fool
Comparing With Pfizer's Vaccine, Icosavax RSV Candidate 'Could Establish Differentiation,' Analyst Says
December 14, 2022
From Benzinga
Options Trader Betting On GSK Stock Rising Heading Into 2023
December 13, 2022
Tickers
GSK
From Benzinga
Wave Life Sciences Shares Move Higher On Therapeutic Pact With GSK Targeting Genetic Disorders
December 13, 2022
From Benzinga
France Health Body Advises Unfavorable Opinion Regarding Valneva's COVID-19 Vaccine
December 08, 2022
From Benzinga
GSK's Jemperli/Chemo Combo Shows Response Rate Of 46% In Head-To-Head Lung Cancer Trial
December 07, 2022
From Benzinga
From Benzinga
From Benzinga
GSK and Sanofi shares surge after Florida ruling dismisses Zantac lawsuits in what one analyst describes as ‘best-case scenario’
December 07, 2022
From MarketWatch
These 3 Stocks Escaped Tuesday's Market Downdraft
December 06, 2022
From Motley Fool
Why GSK Plc And Sanofi SA Stock Are Shooting Higher
December 06, 2022
From Benzinga
Tickers
GSK
From MarketWatch
From Benzinga
Researchers Working On Universal mRNA-Influenza Vaccine Aiming For Baseline Immune Memory For Diverse Strains
November 25, 2022
From Benzinga
After Disappointing Confirmatory Study, GSK To Withdraw Approved Blood Cancer Drug In US
November 22, 2022
Tickers
GSK
From Benzinga
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
November 16, 2022
From Benzinga
FDA Moves Step Closer For Opioid Overdose Medication Access, Says Certain Naloxone Products Can Potentially Be Used In OTC Setting
November 15, 2022
From Benzinga
GSK Touts Encouraging Data From Mid-Stage Tuberculosis Program In Drug-Susceptible Patients
November 14, 2022
Tickers
GSK
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.